Analyst consensus rating
Obsidian Therapeutics Analyst Rating: Strong Buy
OBX is rated Strong Buy by 2 analysts with a $42.50 target. As of 2026-08-22.
Direct answer
Obsidian Therapeutics's consensus rating is Strong Buy.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $42.50.
Forecast evidence checked August 22, 2026.
Get free Obsidian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.90
- Average price target
- $42.50
- High price target
- $43.00
- Low price target
- $42.00
- Low target gap
- +111.1%
- Target upside
- +113.6%
- High target gap
- +116.1%
- Target range width
- 5%
- Consensus rating
- Strong Buy
- Analysts
- 2
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Obsidian Therapeutics?
Obsidian Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $42.50.
How far are Obsidian Therapeutics's low and high targets from the recorded price?
The low target implies +111.1%, while the high target implies +116.1%.
How many analysts are included in Obsidian Therapeutics's consensus?
The verified consensus includes 2 analysts.
How is Obsidian Therapeutics's target upside or downside calculated?
The average target of $42.50 is divided by the recorded price of $19.90, then one is subtracted to produce +113.6%. This does not guarantee a future return.
When was Obsidian Therapeutics's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.